Zajno
- $1k+
- Earned
- 2x
- Hired
Lewes, Delaware
SES AI is a battery technology company accelerating the energy transition through AI-powered material discovery, battery development, manufacturing, and management.
SES AI approached us with a website redesign driven by its new “All-in on AI” strategy. As AI became central to the company’s work across safety, manufacturing, and science, the existing website still focused primarily on its battery-hardware side. We redesigned the experience to clearly communicate the three AI pillars, while making the website simpler, more direct, and easier to navigate.
12
22
603
Zettafleet is a London-based AI startup building a platform for training and managing large language models.
The challenge wasn't simply presenting a complex product. It was building trust in technology that operates behind the scenes. Visually, we leaned into precision. A restrained monochrome palette, generous whitespace, and custom geometric illustrations reflect the systematic nature of machine learning infrastructure while creating a distinctive identity for the brand.
21
31
958
Tech Recruit is an award-winning technology recruitment agency connecting top tech talent with innovative companies across AI, software, robotics, life sciences, semiconductors, and more.
For this project, we designed three interconnected websites for different markets: the global platform, USA Tech Recruit, and European Tech Recruit. To differentiate them while keeping the brand consistent, each received its own primary color identity: blue for the global site, yellow for the US, and green for Europe.
15
30
897
Oxford BioTherapeutics is a biotechnology company focused on developing next-generation oncology treatments through targeted therapies, including antibody-drug conjugates (ADCs), immuno-oncology, T-cell engagers (TCEs), and radiopharmaceuticals.
The goal was to create a restrained, professional digital experience built around stakeholder-focused content and visually clear scientific communication. The hero illustration depicts a T cell activating after detecting a tumor cell, reflecting the company’s work on redefining the cancer–immune synapse and exploring novel immune checkpoint mechanisms.
1
280